Live Oak Investment Partners Makes New Investment in Encompass Health Corporation $EHC

Live Oak Investment Partners bought a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 9,585 shares of the company’s stock, valued at approximately $969,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. boosted its holdings in Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at about $4,881,000. Systematic Financial Management LP raised its position in shares of Encompass Health by 3.6% in the 4th quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock valued at $46,782,000 after acquiring an additional 15,462 shares during the period. Trillium Asset Management LLC boosted its stake in Encompass Health by 5.7% during the 4th quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock worth $23,424,000 after acquiring an additional 11,793 shares during the last quarter. Finally, Global Retirement Partners LLC grew its holdings in Encompass Health by 2,468.6% during the fourth quarter. Global Retirement Partners LLC now owns 11,533 shares of the company’s stock valued at $1,224,000 after purchasing an additional 11,084 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Performance

EHC opened at $121.95 on Thursday. The business’s 50-day moving average price is $110.26 and its two-hundred day moving average price is $106.10. Encompass Health Corporation has a 1 year low of $92.77 and a 1 year high of $127.99. The company has a market capitalization of $12.03 billion, a price-to-earnings ratio of 19.86, a P/E/G ratio of 2.48 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities analysts expect that Encompass Health Corporation will post 6.08 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. This is an increase from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s payout ratio is currently 12.38%.

Wall Street Analyst Weigh In

EHC has been the topic of several analyst reports. Barclays increased their target price on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. UBS Group boosted their price target on shares of Encompass Health from $150.00 to $155.00 and gave the company a “buy” rating in a report on Friday, August 7th. Truist Financial upped their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday. Finally, Weiss Ratings upgraded Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $148.71.

Insider Activity at Encompass Health

In other news, CEO Mark J. Tarr sold 173,148 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the transaction, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares of the company’s stock, valued at $9,451,413.95. The trade was a 10.61% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.